C. Manegold

3.6k citations
82 papers · 2.4k · 1 hit paper · h-index 21

Impact in

    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Lung Cancer Diagnosis and Treatment
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Oncology top 5%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 35
    • Lung Cancer Diagnosis and Treatment 16
    • Occupational and environmental lung diseases 14
    • Pleural and Pulmonary Diseases 7
    • Medical Imaging and Pathology Studies 6
    • Lung Cancer Research Studies 18
    • Colorectal Cancer Treatments and Studies 6

C. Manegold

78 papers receiving 2.4k citations

C. Manegold's Hit Papers

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) 2010 · 496 citations
4960+5+10Years since publication100200300400

Peers

C. Manegold
Comparison fields: 5 of 98
  • Pulmonary and Respiratory Medicine 1.3k
  • Oncology 788
  • Cancer Research 132
  • Clinical Biochemistry 59
  • Neurology 103
Replace Gavin Wright with:
Gavin Wright Australia
Hidehito Horinouchi Japan
William K. Murphy United States
Sculier Jp Belgium
Hans‐Stefan Hofmann Germany
Jean‐Emmanuel Kurtz France
Hans Christiansen Germany
N. H. Mulder Netherlands
Hiroji Uemura Japan
Cosimo Sperti Italy
C. Manegold relative to Gavin Wright Australia Gavin Wright's profile →
Citations per field
00.5×3.5×
Gavin Wright · 1×
Citations per year

Countries citing papers authored by C. Manegold

Since Specialization
Citations

This map shows the geographic impact of C. Manegold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Manegold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Manegold more than expected).

Fields of papers citing papers by C. Manegold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Manegold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Manegold. The network helps show where C. Manegold may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Manegold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Manegold Line = papers co-authored together C. Manegold links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Hit paper breakdown →
2010496
2 2006152
3 2007128
4 2000128
5 2005120
6 2011117
7 2002115
8 2011104
9 2008100
10 200396
11 200985
12 201075
13 201370
14 197966
15 200344
16 200941
17 200437
18 201228
19 200625
20 201122

About C. Manegold

C. Manegold is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 82 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (18 papers), Lung Cancer Diagnosis and Treatment (16 papers), Occupational and environmental lung diseases (14 papers), Pleural and Pulmonary Diseases (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Medical Imaging and Pathology Studies (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Oncology (788 citations), Cancer Research (132 citations), Clinical Biochemistry (59 citations) and Neurology (103 citations). C. Manegold has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Joachim von Pawel, Martin Reck, Petr Zatloukal, Rodryg Ramlau, Vera Hirsh, J. Mezger, Venice Archer, V. Gorbounova, N. B. Leighl and Norman C. Moore. Their work appears in journals such as Annals of Oncology, Lung Cancer, Journal of Clinical Oncology, European Journal of Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact